These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7424181)

  • 21. Appraisal of the narcotic drugs and psychotropic substances (amendment) act, 2014.
    Mohapatra S; Rath N
    Asian J Psychiatr; 2015 Apr; 14():80-1. PubMed ID: 25838083
    [No Abstract]   [Full Text] [Related]  

  • 22. The relevancy of drug control in the United States during the seventies.
    Ingersoll JE
    J Forensic Sci; 1972 Jan; 17(1):3-14. PubMed ID: 4618278
    [No Abstract]   [Full Text] [Related]  

  • 23. The convention on psychotropic substances: why it should be ratified.
    Rosen JA
    J Leg Med (N Y); 1974; 2(3):44-7. PubMed ID: 4546226
    [No Abstract]   [Full Text] [Related]  

  • 24. [European Council: new legal dispositions on drugs and drug traffickers].
    CICIAMS Nouv; 1973; (3):28-32. PubMed ID: 4491675
    [No Abstract]   [Full Text] [Related]  

  • 25. 3. Drug regulations in Switzerland and their application.
    Hippenmeier F
    Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448
    [No Abstract]   [Full Text] [Related]  

  • 26. [Legal basis and significance of manufacturing control in Switzerland].
    Fischer P
    Pharm Acta Helv; 1972; 47(11):629-36. PubMed ID: 4657532
    [No Abstract]   [Full Text] [Related]  

  • 27. [European efforts in drug problems].
    Bertschinger JP
    Ther Umsch; 1971 Apr; 28(4):220-5. PubMed ID: 5575079
    [No Abstract]   [Full Text] [Related]  

  • 28. [European drug market--dream or nightmare?].
    Nord Med; 1974 Jan; 89(1):6-8. PubMed ID: 4819431
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug abuse in Switzerland.
    Siegrist HO
    Int J Addict; 1972; 7(1):167-72. PubMed ID: 5043833
    [No Abstract]   [Full Text] [Related]  

  • 30. The Marihuana Tax Act of 1937.
    Musto DF
    Arch Gen Psychiatry; 1972 Feb; 26(2):101-8. PubMed ID: 4551255
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of the federal government in the development of narcotic antagonists.
    Green AI
    Adv Biochem Psychopharmacol; 1973; 8(0):576-7. PubMed ID: 4795123
    [No Abstract]   [Full Text] [Related]  

  • 32. Legal aspects of regulations pertaining to sale and distribution of analytical standards for drugs of abuse. I.
    Evans JG
    J Chromatogr Sci; 1972 May; 10(5):342-6. PubMed ID: 5066301
    [No Abstract]   [Full Text] [Related]  

  • 33. Marihuana.
    Nahas GG
    JAMA; 1975 Jul; 233(1):79-80. PubMed ID: 1173431
    [No Abstract]   [Full Text] [Related]  

  • 34. [Letter: International cooperation in drugs must be a simplification, not a complication].
    Thrane O
    Nord Med; 1974 Feb; 89(2):35-6. PubMed ID: 4820743
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug problems and the Common Market. Personal views].
    Andersen AH
    Ugeskr Laeger; 1973 Jun; 135(25):1300-1. PubMed ID: 4800706
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug abuse: bluff or reality?].
    Jaminet F
    Rev Med Liege; 1977 May; 32(10):297-316. PubMed ID: 887879
    [No Abstract]   [Full Text] [Related]  

  • 37. Medicine and public affairs: Kennedy urges further pharmaceutical regulation.
    Greenberg DS
    N Engl J Med; 1974 May; 290(21):1211-2. PubMed ID: 4824024
    [No Abstract]   [Full Text] [Related]  

  • 38. Remarks at the Food and Drug Law Institute's 48th Annual Conference.
    Niedelman SM
    Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089
    [No Abstract]   [Full Text] [Related]  

  • 39. [Round table discussion on the Scandinavian drug market: A common pharmacy and therapeutics committee is proposed in view of threats from abroad of lowered standards].
    Nord Med; 1974 Jan; 89(1):3-5. PubMed ID: 4856475
    [No Abstract]   [Full Text] [Related]  

  • 40. Authority for practitioners to dispense or prescribe approved narcotic controlled substances for maintenance or detoxification treatment. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2005 Jun; 70(120):36338-44. PubMed ID: 15973789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.